Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Neurology
|
May 29, 2003
Patient pages. Daily headaches due to medication overuse
Eric Eross
Headache
|
December 17, 2002
"Occult" orthostatic headache
Eric Eross, David Dodick, Kent Nelson
Seminars in Neurology
|
January 15, 2004
Chronic daily headache: a rational approach to a challenging problem
Jonathan Gladstone, Eric Eross, David Dodick
Headache
|
February 16, 2007
The Sinus, Allergy and Migraine Study (SAMS)
Eric Eross, David Dodick, Michael Eross
Neuromodulation : Journal of the International Neuromodulation Society
|
October 14, 2011
Case report: successful epiradicular peripheral nerve stimulation of the C2 dorsal root ganglion for postherpetic neuralgia
Paul J Lynch, Tory McJunkin, Eric Eross, et al.
The Journal of Headache and Pain
|
May 29, 2021
Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials
Jakub Jedynak, Eric Eross, Astrid Gendolla, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Neurology
|
May 29, 2003
Patient pages. Daily headaches due to medication overuse
Eric Eross
Headache
|
December 17, 2002
"Occult" orthostatic headache
Eric Eross, David Dodick, Kent Nelson
Seminars in Neurology
|
January 15, 2004
Chronic daily headache: a rational approach to a challenging problem
Jonathan Gladstone, Eric Eross, David Dodick
Headache
|
February 16, 2007
The Sinus, Allergy and Migraine Study (SAMS)
Eric Eross, David Dodick, Michael Eross
Neuromodulation : Journal of the International Neuromodulation Society
|
October 14, 2011
Case report: successful epiradicular peripheral nerve stimulation of the C2 dorsal root ganglion for postherpetic neuralgia
Paul J Lynch, Tory McJunkin, Eric Eross, et al.
The Journal of Headache and Pain
|
May 29, 2021
Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials
Jakub Jedynak, Eric Eross, Astrid Gendolla, et al.
Page
of 1